相似文献
1
Lymphocytes in cancer development: polarization towards pro-tumor immunity.
Cytokine Growth Factor Rev. 2010 Feb;21(1):3-10. doi: 10.1016/j.cytogfr.2009.11.002. Epub 2009 Dec 11.
2
Tumor-infiltrating T lymphocytes: friends or foes?
Lab Invest. 2006 Mar;86(3):231-45. doi: 10.1038/labinvest.3700389.
3
Immunological changes in simian immunodeficiency virus (SIV(agm))-infected African green monkeys (AGM): expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIV(agm).
J Gen Virol. 2002 Mar;83(Pt 3):631-640. doi: 10.1099/0022-1317-83-3-631.
4
Differentiation and Regulation of T Cells: A Balancing Act for Cancer Immunotherapy.
Front Immunol. 2021 May 3;12:669474. doi: 10.3389/fimmu.2021.669474. eCollection 2021.
5
Phenotypic maturation of porcine NK- and T-cell subsets.
Dev Comp Immunol. 2013 May;40(1):51-68. doi: 10.1016/j.dci.2013.01.003. Epub 2013 Jan 22.
6
The role of T lymphocytes in the immunotherapy of tumours.
Biomed Sci. 1991;2(5):441-9.
7
CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer.
Mod Pathol. 2013 Mar;26(3):448-55. doi: 10.1038/modpathol.2012.164. Epub 2012 Oct 5.
8
The significance of Treg cells in defective tumor immunity.
Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):181-91. doi: 10.1007/s00005-008-0018-1. Epub 2008 May 30.
9
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model.
J Vis Exp. 2015 Apr 13(98):52657. doi: 10.3791/52657.
10
Multiple roles for CD4+ T cells in anti-tumor immune responses.
Immunol Rev. 2008 Apr;222:129-44. doi: 10.1111/j.1600-065X.2008.00616.x.
引用本文的文献
1
Pesticide exposome reveals oxidative stress and immune response disruptions in occupationally exposed women with breast cancer.
Sci Rep. 2025 Aug 22;15(1):30910. doi: 10.1038/s41598-025-12870-2.
2
Lymphocyte-C-Reactive Protein Ratio: Impact on Prognosis of Patients Following Resection of Primary Liver Cancer.
World J Surg. 2025 Aug;49(8):2195-2206. doi: 10.1002/wjs.12675. Epub 2025 Jun 17.
3
RON Receptor Signaling and the Tumor Microenvironment.
Genes (Basel). 2025 Apr 6;16(4):437. doi: 10.3390/genes16040437.
4
Multi-omics insights into the roles of CCNB1, PLK1, and HPSE in breast cancer progression: implications for prognosis and immunotherapy.
Discov Oncol. 2025 Apr 5;16(1):471. doi: 10.1007/s12672-025-02282-z.
5
The Therapeutic Potential of Physical Exercise in Cancer: The Role of Chemokines.
Int J Mol Sci. 2024 Dec 23;25(24):13740. doi: 10.3390/ijms252413740.
6
Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents.
Biology (Basel). 2024 Nov 24;13(12):967. doi: 10.3390/biology13120967.
7
Genetically predicted Caspase 8 levels mediates the causal association between CD4+ T cell and breast cancer.
Front Immunol. 2024 Sep 26;15:1410994. doi: 10.3389/fimmu.2024.1410994. eCollection 2024.
8
Performance of nutritional and inflammatory markers in patients with pancreatic cancer.
World J Clin Oncol. 2024 Aug 24;15(8):1021-1032. doi: 10.5306/wjco.v15.i8.1021.
9
Cancer immunotherapy and its facilitation by nanomedicine.
Biomark Res. 2024 Aug 3;12(1):77. doi: 10.1186/s40364-024-00625-6.
10
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.
Cancer Immunol Immunother. 2024 May 7;73(7):117. doi: 10.1007/s00262-024-03699-1.
本文引用的文献
1
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.
Cancer Cell. 2009 Aug 4;16(2):91-102. doi: 10.1016/j.ccr.2009.06.018.
2
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.
J Exp Med. 2009 Jul 6;206(7):1457-64. doi: 10.1084/jem.20090207. Epub 2009 Jun 29.
3
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.
Carcinogenesis. 2009 Jul;30(7):1073-81. doi: 10.1093/carcin/bgp127. Epub 2009 May 25.
4
Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?
Immunity. 2009 May;30(5):626-35. doi: 10.1016/j.immuni.2009.05.002.
5
Control of regulatory T cell lineage commitment and maintenance.
Immunity. 2009 May;30(5):616-25. doi: 10.1016/j.immuni.2009.04.009.
6
A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.
Am J Clin Oncol. 2009 Jun;32(3):269-73. doi: 10.1097/COC.0b013e318187dd40.
7
Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.
J Clin Invest. 2009 Jun;119(6):1524-36. doi: 10.1172/JCI37869.
8
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.
J Hepatol. 2009 May;50(5):980-9. doi: 10.1016/j.jhep.2008.12.033. Epub 2009 Mar 11.
9
Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.
Immunity. 2009 Mar 20;30(3):458-69. doi: 10.1016/j.immuni.2008.12.022.
10
Endogenous IL-17 contributes to reduced tumor growth and metastasis.
Blood. 2009 Jul 9;114(2):357-9. doi: 10.1182/blood-2008-09-177360. Epub 2009 Mar 16.
Zotero 插件